Summary and future considerations Despite delivering significant weightloss and health benefits, GLP1 medications also present important limitations, including gastrointestinal side effects, nutrient shortfalls from the diet, loss of muscle mass, high costs, frequent discontinuation, and weight regain once treatment stops
Cancers (Basel) 15
12 Commonly, patients may experience gastrointestinal disturbances such as nausea, vomiting, diarrhea, and constipation
Growth hormone peptides (CJC-1295, Ipamorelin, MK-677) cycle 8 to 12 weeks with 4 weeks off
How do GLP-1s, like Zepbound or Wegovy, affect people with papillary thyroid cancer
Back Roberts, R (9 Dec 2015) 'Sickening Sweet', Science Institute Museum and Library